Zhihua Zheng Selected Research

Hypertension (High Blood Pressure)

10/2021

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhihua Zheng Research Topics

Disease

11	Neoplasms (Cancer) 03/2022 - 05/2013
3	Infections 10/2020 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 10/2020 - 05/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2021
2	Insulin Resistance 01/2022 - 01/2021
2	Chronic Renal Insufficiency 10/2021 - 12/2013
2	COVID-19 01/2021 - 01/2020
2	Adenocarcinoma 01/2021 - 09/2020
2	Acute Kidney Injury (Acute Renal Failure) 12/2020 - 10/2018
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 01/2018
2	Inflammation (Inflammations) 10/2018 - 02/2010
1	Human Influenza (Influenza) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2022
1	Carcinogenesis 03/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Shock 01/2022
1	Catheter-Related Infections 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2021
1	Obesity 10/2021
1	Atherosclerosis 10/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Reperfusion Injury 12/2020
1	Persistent Infection 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Lymphatic Metastasis 10/2020

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 02/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2021
2	LipidsIBA 01/2022 - 01/2021
2	Angiotensin IIIBA 10/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2020
2	InterferonsIBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 10/2020 - 01/2015
2	Long Noncoding RNAIBA 10/2020 - 09/2020
2	Pattern Recognition ReceptorsIBA 01/2020 - 01/2018
2	InterleukinsIBA 10/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 10/2018 - 01/2018
2	CreatinineIBA 10/2018 - 01/2015
2	CytokinesIBA 10/2018 - 01/2018
1	COVID-19 VaccinesIBA 12/2022
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 03/2022
1	Thyroid HormonesIBA 01/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	IronIBA 01/2022
1	CateninsIBA 01/2022
1	CatecholaminesIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	MetalsIBA 01/2022
1	AmmoniaIBA 12/2021
1	BilirubinIBA 12/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 10/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2021
1	Biological ProductsIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	periodate-oxidized adenosineIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2021
1	InflammasomesIBA 01/2021
1	NLR ProteinsIBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2020
1	Vasoconstrictor AgentsIBA 12/2020
1	Carrier Proteins (Binding Protein)IBA 12/2020
1	Bone Cements (Bone Glue)IBA 10/2020
1	Hemoglobins (Hemoglobin)IBA 10/2020
1	Serum AlbuminIBA 10/2020
1	Competitive Endogenous RNAIBA 10/2020
1	alpha2 Subunit Collagen Type IIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	peptidoglycan recognition proteinIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2018

Therapy/Procedure

2	Peritoneal Dialysis 09/2015 - 02/2010
1	Continuous Renal Replacement Therapy 01/2022
1	Catheters 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Plasma Exchange 12/2021
1	Jejunoileal Bypass 01/2021
1	Bariatric Surgery 01/2021
1	Immunotherapy 01/2021
1	Surgical Amputation (Amputations) 10/2020
1	Blood Transfusion (Blood Transfusions) 10/2020
1	Debridement 10/2020
1	Drug Therapy (Chemotherapy) 10/2020
1	Prostheses and Implants (Prosthesis) 10/2020
1	Limb Salvage 10/2020
1	Therapeutics 01/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2018